SI-BONE, Inc.
NASDAQ:SIBNMedical - Devices
+$0.53 today
- Market cap
- $1.06B
- Beta
- 0.70
- P/E (TTM)
- -41.4
- EPS (TTM)
- -$0.38
Volume 1.12M
Average 0.68M
SIBN Total Equity
Shareholders' claim on the company's assets after all liabilities: total assets minus total liabilities.
SI-BONE, Inc.NASDAQ: SIBN
Total Equity · Q1 FY2026 · quarter ended Mar 2026
Total equity rises 7.0% from a year ago
Total equity stood at $178.94M at the end of Q1 FY2026, up 7.0% from a year earlier and up 0.8% from the prior quarter. Over 3 fiscal years it compounded at +21.8% a year.
Context
- Total equity amounted to 73.7% of total assets at the end of Q1 FY2026, up 0.1 pp from a year earlier.
- Total equity increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether total equity keeps rising in the next quarterly balance sheet after a +7.0% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Equity history
USD · from the balance sheet
- Latest · FY2025
- 177.53M USD
- Year-over-year change
- +6.3%
- 4-year CAGR
- +7.2%
| Period | Period end | Total Equity | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 177.53M | +6.3% |
| FY2024 | 2024-12-31 | 166.96M | -1.4% |
| FY2023 | 2023-12-31 | 169.38M | +72.3% |
| FY2022 | 2022-12-31 | 98.3M | -26.9% |
| FY2021 | 2021-12-31 | 134.42M | — |
Total Equity vs competitors
How SIBN compares with its peers on the latest reported figures
- SIBN's Mar 2026 total equity of $178.94M is the 5th highest of the 6 companies compared; the peer median is $4.77B.
- Its year-over-year change of +7.0% is the 4th highest of 6, against a peer median of +11.0%.
- Total equity amounts to 73.7% of total assets for SIBN, versus a peer median of 50.0%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | $23.99B | +13.2% | +10.5% | 50.0% | |
| Dec 2025 | $5.29B | +0.5% | +0.2% | 50.6% | |
| Jun 2026 | $4.77B | +11.0% | +35.3% | 86.9% | |
| Mar 2026 | $1.02B | +4.1% | +11.5% | 44.0% | |
| Mar 2026 | $178.94M | +7.0% | +21.8% | 73.7% | |
| Mar 2026 | $18.26M | +129.3% | — | 2.3% | |
| Peer median (excluding SIBN) | $4.77B | +11.0% | +11.0% | 50.0% | |
Competitors are the stored peer set for SIBN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 63.42M | 20.72M | 33.27M | 34.95M | 42.24M |
| Short-term Investments | 83.56M | 76.57M | 132.75M | 115.09M | 105.58M |
| Net Receivables | 14.25M | 20.67M | 21.95M | 27.46M | 29.92M |
| Inventory | 11.5M | 17.28M | 20.25M | 27.07M | 33.9M |
| Other Current Assets | 0 | 2.37M | 3.17M | 3.2M | 4.48M |
| Total Current Assets | 175.87M | 137.61M | 211.39M | 207.78M | 216.12M |
| Property, Plant & Equipment (Net) | 14.24M | 19.57M | 18.71M | 22.36M | 22.39M |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 |
| Long-term Investments | 0 | 0 | 0 | 0 | 0 |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 400K | 375K | 325K | 300K | 55K |
| Total Non-current Assets | 14.64M | 19.94M | 19.03M | 22.66M | 22.44M |
| Total Assets | 190.51M | 157.55M | 230.43M | 230.44M | 238.56M |
| Account Payables | 3.2M | 6.28M | 4.59M | 6.49M | 4.63M |
| Short-term Debt | 0 | 0 | 0 | 0 | 944K |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 11.36M | 12.34M | 15.16M | 14.85M | 19.7M |
| Total Current Liabilities | 16.89M | 21.18M | 23.46M | 27.13M | 25.28M |
| Long-term Debt | 34.97M | 35.17M | 36.07M | 35.45M | 175K |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 57K | 30K | 18K | 10K | 35.57M |
| Total Non-current Liabilities | 39.2M | 38.07M | 37.59M | 36.34M | 35.74M |
| Total Liabilities | 56.09M | 59.25M | 61.05M | 63.47M | 61.02M |
| Common Stock | 3K | 3K | 4K | 4K | 4K |
| Retained Earnings | (295.85M) | (357.11M) | (400.44M) | (431.35M) | (450.26M) |
| Accumulated OCI | 352K | 232K | 335K | 244K | 816K |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 134.42M | 98.3M | 169.38M | 166.96M | 177.53M |
| Total Debt | 40.48M | 39.43M | 38.99M | 37.48M | 1.12M |
| Net Debt | (22.94M) | 18.71M | 5.72M | 2.54M | (41.12M) |
SI-BONE, Inc.
NASDAQ:SIBN
Intrinsic Alpha fair value
Locked
Current Price
$23.54
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.